Deletion or mutation of the SAP gene is associated with the X-linked lymphoproliferative disease (XLP) that is characterized by extreme sensitivity to Epstein-Barr virus (EBV). Primary infection of the affected individuals leads to serious, sometimes fatal infectious mononucleosis (IM) and proneness to lymphoma. Our present results revealed a proapoptotic function of SAP by which it contributes to the maintenance of T-cell homeostasis and to the elimination of potentially dangerous DNA-damaged cells. Therefore, the loss of this function could be responsible for the uncontrolled T-cell proliferation in fatal IM and for the generation of lymphomas. We show now the role of SAP in apoptosis in T and B lymphocyte-derived lines. Among the clones of T-ALL line, the ones with higher SAP levels succumbed more promptly to activation induced cell death (AICD). Importantly, introduction of SAP expression into lymphoblastoid cell lines (LCL) established from XLP patients led to elevated apoptotic response to DNA damage. Similar results were obtained in the osteosarcoma line, Saos-2. We have shown that the anti-apoptotic protein VCP (valosincontaining protein) binds to SAP, suggesting that it could be instrumental in the enhanced apoptotic response modulated by SAP.
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activation induced cell death ͉ apoptosis ͉ lymphomas ͉ p53 X -linked lymphoproliferative disease (XLP) is a rare primary immunodeficiency that manifests most often after primary Epstein-Barr virus (EBV) infection (1) . The XLP phenotype includes fatal infectious mononucleosis (fatal IM) (50%), malignant lymphomas (30%), and dys-gammaglobulinemia (30%). Mutations found in XLP patients in the gene located on Xq25 identified the molecular basis of the disease (2) (3) (4) . The XLP gene (SH2D1A) codes for a short protein, SAP, of 128 aa, that contains an SH2 domain through which it binds to receptors of the signaling lymphocytic activation molecule (SLAM and CD150) family, including 2B4 (CD244), NTB-A, CD84, Ly9 (CD229), and CD2-like receptor-activating cytotoxic cells (CRACC). These molecules are expressed in cells of the immune system [for a review see Veillette (5) ].
The majority of point mutations in the SAP gene lower markedly the stability of the protein, leading to its loss (6) . Other mutations disrupt its binding to the SLAM family receptors.
IM is an immunopathological disease, characterized by lymphocytosis as a result of expansions of NK cells and CD8ϩ T lymphocytes in response to the primary EBV infection (7) . The severity of the disease varies, but it subsides regularly. In contrast, the course of primary EBV infection in XLP patients is always severe. In 50% of the cases, it leads to death (fatal IM) caused by overwhelming cytotoxic T-cell activation and multiorgan failure.
In addition to the intense proliferation of T cells, the high frequency of apoptosis prone T lymphocytes is an important feature of IM (8) . Upon resolution of the disease, the absolute number of circulating T cells and the relative proportion of CD4 ϩ and CD8ϩ returns to normal (9) .
The NK cells of XLP patients are functionally impaired (10) , and it has been shown that SAP controls the cytotoxic functions of NK and T cells (11, 12) . Thus, lack of the SAP protein explains the decreased cell mediated cytotoxic activity in XLP patients. Since T and NK cells are held responsible for the elimination of EBVinfected B cells, it was suggested that mainly the inefficiency of these effector cells is responsible for the prolonged, severe and often fatal disease course.
Assuming that SAP has further functions, in that it may control the amplitude and duration of the immune response during the primary EBV infection, we tested whether the increase of SAP expression in the late phases of T-cell activation, correlates with the resolution of the cellular immune response.
Our earlier work showed that wt p53 induces SAP in lymphoid cells (13) , suggesting the possibility that SAP is an executor molecule in some of the several p53 controlled pathways. P53 is a multifunctional regulator having a central role in several cellular pathways such as cell-cycle control, apoptosis, and DNA repair, contributing critically to the maintenance of genomic stability and suppression of cell transformation.
We studied therefore the effect of SAP overexpression in different cell types in situations that could reflect the course of 2 events in XLP patients: (i) the homeostasis of T cells in IM and (ii) the fate of cells subjected to genotoxic stress in the process of lymphoma development.
Our results identified SAP as a proapoptotic cellular protein, suggesting an unexpected role in the pathology of XLP disease.
Results

SAP Is
Up-Regulated in PHA-Activated T Cells. Cognate stimulation of T cells induces their activation and proliferation. Ultimately however, activated T cells succumb by apoptosis and the T-cell number declines. Our earlier finding that SAP is increased in the late phases of T-cell activation (14) suggested that in addition to its known function in regulating signals at the initiation of T-cell activation, SAP may regulate T-cell homeostasis. This assumption is supported by the kinetic analysis of PHA-activated T cells in that the expression of SAP, and the proliferation of the cells (measured by 3 H-Thy incorporation) showed a negative correlation (Fig. 1A) .
P53 is up-regulated in the activated T cells (Fig. 1B) , and according to our earlier finding, p53 induces SAP expression. Therefore, it is likely that SAP up-regulation in activated T cells may involve p53.
ery to the cells and obtained 4 sublines with low SAP (CCRF-HSB2-vector) and 4 sublines with high SAP (CCRF-HSB2-SAP) expression. In subsequent experiments, we used 2 low and 2 high SAP expressor sublines (Fig. 2) .
The phenotype of the 4 sublines determined by FACS showed no differences in expression of CD25, CD69, CD95, ICAM-1, LFA-1, SLAM, and 2B4.
The expression of the anti-apoptotic proteins Bcl-2 and Bcl-xl, detected by immunoblot, did not differ either in the 4 lines (Fig. 2) .
CCRF-HSB2 Clones Expressing High SAP Levels Are More Sensitive to
Activation-induced Cell Death. T-cell homeostasis is controlled by activation induced cell death (AICD), in which apoptotic process is initiated when activated T cells are restimulated. We used the in vitro model of AICD that is activation of cells by PMAϩ ionomycin or PHA.
During the 6-day period of the test, the number of viable cells in the culture initiated with the high SAP expressor hardly increased (Fig. 3A) . This was due, at least in part, to higher death rate in the population of the high SAP expressors (85%) compared with lower SAP expressors (35%) following activation with 100 ng/mL PMA ϩ 4 M ionomycin. The results with PHA activated (5 g/mL) cells were similar (40% versus 18%).
By definition, the AICD occurs through apoptosis. Therefore, in the next experiment, we determined the kinetics of the appearance of Annexin V-positive cells in PMA ϩ ionomycin-treated cultures. The kinetics and dose dependence of appearance of Annexin V-positive cells showed that the highest concentration of drugs (200 ng/mL PMA ϩ 8 M ionomycin) induced massive apoptosis already after 2.5 h (Fig. 3B ). In the cultures treated with the lower doses, apoptotic cells appeared after 6 and 22 h. At all time points and concentrations, significantly higher percentages of apoptotic cells were detected in the cultures of the cells that expressed higher SAP levels (Fig. 3B ). This was accompanied by a higher level of activation of caspases (Fig. 3C ) and PARP cleavage (Fig. 3D) . Thus, the levels of SAP in the T cells correlated with sensitivity to AICD.
AICD involves the function of the death receptor CD95. Therefore, we tested the sensitivity of the CCRF-HSB2 clones to the agonistic anti-CD95 Ab (anti-APO-1). This comparison was feasible because CD95 expression was similar on the sublines. Ligation of CD95 induced higher number of apoptotic cells in the clones with higher SAP level (22% versus 12%), further substantiating the involvement of SAP in AICD.
SAP Controls Cell Cycle/Apoptosis in DNA-damaged Saos-2 Cells. We reported earlier that SAP is a p53 target in lymphoid cells. Thus, SAP could execute some of the p53 functions. We tested this assumption in the osteosarcoma cell line, Saos-2, which lacks p53. We induced DNA damage by irradiation in Saos-2 cells into which SAP was introduced by retroviral transduction and could therefore investigate the direct involvement of SAP without the contribution of p53.
In short-term experiments, the division of cells was monitored by the dilution of the membrane dye PKH26. The SAP positive cells did not divide during 2 days following DNA damage (400 rad) whereas the Saos-2-vector cells divided as indicated by the decrease of fluorescence intensity (Fig. 4A, Lower) .
The cells were also followed for a longer time period. Seven days after irradiation, the Saos-2-vector cultures contained several growing colonies, whereas no colonies were seen in the Saos-2-SAP cultures (Fig. 4B , Left). Ten days after the initiation of cultures, viable colonies were detected by MTT assay only in the SAPnegative cultures (Fig. 4B , Right).
We also followed the fate of the irradiated Saos-2 cells during an extended period. Three days after irradiation of the cells, cultures were initiated with equal cell numbers and kept for 28 days. The total number of cells was lower in the Saos-2-SAP cultures compared with Saos-2-vector cells (Fig. 4C) , indicating that the expression of SAP was required to compromise cell proliferation after irradiation.
The experiments with the Saos-2 lines suggest thus that SAP is involved in the cell cycle control/apoptosis of DNA-damaged cells. To elucidate the functional consequences of a mutated SAP, we compared the cell cycle distribution of EBV-transformed lymphoblastoid cell lines (LCLs) derived from healthy donors and from XLP patients (carrying wt p53), following DNA damage (doublestrand breaks) induced by ␥-irradiation. We have previously shown that LCLs do not express SAP, but it can be induced when cells are exposed to DNA damage because p53 activates the SAP promoter (13) . Since the SAP gene is mutated or it is deleted in the XLP patients, they will lack or express mutated/truncated SAP following DNA damage. Although the healthy donor derived LCLs arrested in the G2/M phase of the cell cycle following irradiation (Fig. 5A ), this did not occur with the XLP patient-derived LCLs (Fig. 5B ). This result suggested the involvement of SAP in the cell cycle control/DNA repair/apoptosis in that a nonfunctional SAP would be unable to induce a normal DNA damage response, manifested by failure to induce growth arrest in G2/M phase of the cell cycle. 
Constitutive Expression of SAP Renders LCLs More Sensitive to Apoptosis.
To confirm that SAP is responsible for cell cycle regulation /apoptosis in lymphoid cells, we introduced SAP into LCLs established from XLP patients (TR and K001-BK) with the help of retrovirus delivery system. The cells constitutively expressed a low, but stable level of SAP. Twenty-four hours after irradiation of these cells with 1,000 rad, we tested the cell cycle distribution. The LCLs that express SAP showed a significantly higher number of dead cells (with DNA content in the sub G1 fraction) (Fig. 6A) . Similar results were obtained with the other LCL, K001-BK, where the SAP expressor cultures had higher percentage of dead cells at all time points tested after irradiation (Fig. 6B) . These results strongly suggest that SAP is involved in the elimination of DNA damaged cells.
SAP Binds VCP, a Protein with Anti-Apoptotic Function.
In an attempt to identify the apoptosis regulatory pathway(s) with which SAP might interfere, we looked for SAP-binding partners by coimmunoprecipitation. CCRF-HSB2 cells were lysed and precipitated with anti-SAP antibody and with normal rabbit serum (NRS) as a negative control. After SDS-PAGE, the proteins were visualized by silver staining, and bands present in the anti-SAP precipitates but absent from NRS precipitates were subjected to mass spectrometry analysis. As a validation of the method's specificity, a protein band of Ϸ15 kDa was confirmed as SAP. One of the coprecipitated proteins, with a molecular weight of Ϸ100 kDa, was identified as valosin-containing protein (VCP). This protein has been shown to be involved in regulation of apoptosis, making it an attractive candidate by which SAP could regulate apoptosis. Subsequently, we precipitated endogenous SAP from CCRF-HSB2 cells and transiently transfected SAP from Saos-2 cells. The immunoprecipitated samples were probed in western blot with anti-VCP antibodies and this confirmed the binding of SAP to VCP (Fig. 7A) . However, in the reciprocal experiments, SAP was not detected in the precipitates obtained with VCP-specific antibodies. To rule out that the negative result was because of the specificity and/or affinity of the VCP antibody, we constructed a Myc-tagged VCP plasmid and expressed it in Saos-2 cells together with SAP. Again, binding of SAP to Myc-VCP was proven (Fig. 7B ), but SAP was not found in the immunoprecipitates obtained with the anti-Myc reagents. This may be because interaction of VCP with SAP is dynamic. In addition, endogenous VCP may compete with the Myc-tagged VCP for binding SAP.
Discussion
With rare exceptions, all humans carry Epstein-Barr virus (EBV). Primary infection of adolescents and young adults induces a selflimiting disease, infectious mononucleosis (IM) in approximately half of the individuals (15)
. The clinical picture of IM is highly variable, ranging from mild to severe symptoms (16) . Silent infection, that is the rule in young children, can be detected by the development of humoral and cellular EBV-specific immunity.
XLP has been considered as an EBV-specific immunodeficiency, because the severe, often fatal disease follows EBV infection, leading to the death of the patient in 50% of cases. However, individuals with this genetic defect do not have altered response to other herpesviruses. However, they exhibit humoral immune dysfunctions and a 200 -times higher risk for the development of malignant lymphomas than the general population.
The symptoms of IM reflect the involvement of the immune system. EBV infection elicits a dramatic increase in the numbers of NK and CD8ϩ T cells. The activated CD8 lymphocytes, which can account for Ͼ50% of the total blood lymphocyte population (7), release cytokines that are predominantly of a Th1 type (IFN-␥ and IL-2) (17, 18) and are thought to induce the clinical features.
The high apoptotic rate of T cells (19, 20) , as a consequence of a markedly decreased expression of Bcl-2 and high levels of FasL, is an important factor in the recovery from IM. Normally, the CD8 Tcell responses subside and in the contraction phase the majority of virus-specific CD8 T cells die while a pool of memory cells emerges. It is possible that the regulation of the T-cell dynamic is also impaired in XLP patients. This has already been suggested by the elevated numbers of T cells found in SAP-deficient mice infected with either LCMV or with murine gammaherpesvirus-68 (21, 22) .
The aim of our studies was to elucidate the role of SAP in the termination of the intense immune response elicited by primary EBV infection. We have previously shown that SAP was upregulated in T cells activated with PHA or with allogeneic irradiated LCLs (23) . The indication that SAP may be involved in the termination of T-cell responses emerged from the kinetic studies on SAP levels and cell proliferation, which showed an inverse correlation between these 2 parameters. These results suggested that the high SAP levels in the late phases of activation have a negative effect on cell proliferation/survival.
T-cell homeostasis involves activation-induced cell death (AICD), in which restimulation of the activated T cells initiates apoptosis. Our comparative experiments with T-cell tumor clones showed that T cells with high SAP levels responded more readily in the AICD test. These results with the tumor lines suggest the involvement of SAP in AICD that may be valid for primary T cells as well. Therefore, the absence of functional SAP in the XLP patients could allow extended survival of over-activated T cells in IM, and their persistence could lead to the massive tissue infiltrates and organ failures seen in fatal IM. A link between high in vivo SAP levels and rapid apoptosis of lymphocytes in acute IM can be inferred from a recently published study. Analysis of IM blood revealed that at the time of diagnosis, SAP expression in PBMC was higher than in control subjects. This was probably followed by massive apoptosis in the IM blood, since a few days after diagnosis (3-16 days), the lymphocyte counts returned to normal (9) .
However, why would the defective AICD, caused by nonfunctional SAP, manifest specifically in primary EBV infection? We propose that it is because of the exceptional relation of the virus and the immune system. The virus infects the B cells that become activated and proliferate. The B blasts, present in high numbers, express high levels of costimulatory molecules and therefore stimulate the T cells more intensely than in other infections. Thus, following the elimination of the infected B cells, an efficient homeostasis of the activated T cells is particularly important for recovery from IM. The evidence presented here suggests a deficient-T-cell homeostasis in the individuals that lack SAP. The extraordinary high numbers of activated T cells will escape AICD, they will survive, leading to the development of fatal IM. In addition, the defective cytotoxic function of CTLs and NK cells would contribute to the vicious cycle, the persistence of EBVinfected B cells would continuously activate T cells.
Similarly, SAP-deficient, OT-I TCR transgenic mouse CD8 T cells showed a defective AICD, associated with lower levels of p73 that influences the mitochondrial cell death pathway (24) . Interestingly, this phenotype was seen only in primary CD8 T-cell responses.
It has been assumed that malignant lymphomas appear with very high frequency in XLP patients because of deficient NK and CD8ϩ cytotoxic T cell-mediated control of EBV-infected, proliferating B cells. However, data are missing to support this hypothesis. The presence of EBV in the XLP lymphomas often has not been documented and more recent data clearly proves the existence of lymphomas in EBV-negative patients (25) . Moreover, in a retrospective study on XLP patients from the XLP registry, Sumegi et al. found that if FIM is excluded (which occurs only in EBV-positive patients), the frequency of lymphoproliferative disease is the same in EBV-seronegative and -positive XLP patients (26) . Therefore, in addition to the disturbance in the EBV-specific immune response, the absence of functional SAP has to affect the B cells as well.
In our previous work, we showed that SAP is a target of the tumor suppressor p53 (13) . This finding motivated further experiments to establish whether SAP is involved in some of the many functions of p53.
We studied therefore the fate of cells exposed to genotoxic stress in relation to their SAP expression. We previously showed that LCLs do not express SAP, but as a consequence of p53 activation, it is induced after DNA damage (13) . Cell cycle distribution revealed that in LCLs derived from healthy donors, but not in the LCLs established from XLP patients, DNA damage induces G2/M arrest. Even though the same results were seen consistently on 2 healthy donor and 2 XLP derived LCLs, we could not rule out the possibility that independently of SAP expression the cell lines differ in other properties. However, results with the Saos-2 osteosarcoma line and with LCLs into which SAP was introduced substantiated the role of SAP in the sensitivity to DNA damage in that they died more promptly.
In these experiments, however, the results in the comparison of LCLs derived from healthy donors and XLP patients and the reconstitution of SAP into the XLP-derived LCL differed. In the former, the presence of SAP led to accumulation of cells in G2/M phase, although in the latter comparison it led to more pronounced apoptosis. The difference between these 2 systems may be a consequence of the difference in the kinetics and amplitude of the response to irradiation. In the ''normal'' LCLs, SAP was induced by p53, although in the reconstituted XLP LCLs, SAP was ectopically expressed, and thus presented from the first moment of the DNA-damage induction.
Altogether, the results consistently indicate that p53 induced SAP may operate in the elimination of cells with compromised DNA. The introduction of double-strand breaks into DNA triggers a complex set of responses, such as cell cycle arrest, relocalization of DNA repair factors, and apoptosis. Failure to induce these responses in cells with DNA damage can increase the probabilities for oncogenic transformation. We can therefore conclude that the lack of SAP function may allow survival/proliferation of lymphocytes that carry mutations, cells that may eventually become malignant.
We have thus provided evidence that SAP participates in apoptosis. Furthermore, our results suggest that by binding to SAP, VCP may be involved in the regulation of this pathway. VCP (also called p97) is ubiquitous, essential, and abundantly expressed in cells. It has an unusually wide variety of functions. Among others, VCP has an anti-apoptotic function as it has been proven in different systems. For example, in MCF7 cells, VCP was shown to be a target of Akt; thus, it is required for cell survival. Its silencing with siRNA had a potent proapoptotic effect (27) . Moreover, studies in yeast showed that a mutant Cdc48 (S565G), that is a highly conserved yeast orthologue of human VCP, caused mitochondrial dysfunction, accumulation of cytochrome c in the cytosol, caspase activation, and apoptosis (28) . In addition, it has been shown that VCP is involved in the DNA-damage response pathway (29) . These previous findings suggest that the demonstration of SAP binding to VCP has a biological significance and may be the critical mediator whereby SAP exerts its apoptotic function. It is conceivable that SAP can preclude VCP from exerting its antiapoptotic function, a net result being a proapoptotic response of the cells that express SAP.
We have thus identified SAP as a proapoptotic molecule being regulated by p53. It may work through inhibition of the anti-apoptotic function of VCP. With regard to the XLP pathology, we propose the following scenario. In the absence of SAP function, AICD of T cells (homeostasis) is impaired, leading to their uncontrolled proliferation, seen in fatal IM, and DNA damaged lymphoid cells, which would normally die, might escape death. If some of these cells would still be able to divide, they might carry mutations and chromosomal aberrations that could contribute to lymphoma development.
Materials and Methods
Cell Lines and Treatments. Nadia, LS, TR, and K001-BK are lymphoblastoid cells lines (LCLs). The last 2 LCLs were generated from XLP patients. TR has a complete deletion of SAP gene, while K001-BK has deletion of exon 2 (26) . Saos-2 is a p53-null osteosarcoma cell line. CCRF-HSB2-vector and -SAP cells were activated with the indicated concentrations of PMAϩ ionomycin or 5 g/mL PHA. Cells were counted using erythrosin B (Sigma) for detection of dead cells. For testing the sensitivity of clones to anti-CD95, the cells were treated with anti-APO-1 and protein A (Sigma). Annexin V-positive cells were detected by flow cytometry using the annexin V-FITC detection kit (BD PharMingen) following the manufacturer's protocol.
DNA-Damage Induction and Cell Cycle Analysis. Gamma irradiation was performed in a CIS IBL 637. After the indicated times, cells were collected, washed and resuspended in 0.5 mL PBS, and 1 mL 99% ice-cold ethanol was added. Samples were kept at 4°C until next day when after washing with PBS, 1 mL of 0.1% Triton X-100, 20 g/mL propidium iodide ,and 50 g/mL RNase A was added. After a 20-min incubation at 37°C, samples were run on a Becton Dickinson FACScan flow cytometer (Becton Dickinson). The CellQuest Plus software (Becton Dickinson) was used both for acquisition and analysis of the samples.
Separation and Activation of Primary T Cells. Peripheral blood mononuclear cells (PBMCs) were separated from buffy coats of healthy blood donors by Ficoll-Paque (Amersham Pharmacia). T cells were obtained by negative selection. Cells were cultured in medium alone or in the presence of 1 g/mL PHA. On the indicated time points, 0.1 ϫ 10 6 cells were plated in 200 L medium in a 96-well plate. One Ci 3 H-thymidine was added to each well and incubated at 37°C in 5% CO2 for 16 h. The cells were harvested on a glass fiber filter, and radioactivity was measured in a liquid scintillation counter. All data represent the mean value given by 5 parallel wells.
Immunoblotting. The cells were lysed in loading buffer and aliquots corresponding to 2 ϫ 10 5 cells were loaded on each lane. Immunoblotting has been carried out as described in ref. 14. For detection of different proteins the following Abs were used: a rabbit anti-SAP serum (kind gift of J. Sü megi); DO-7 mAb: p53; mAb Clone 124: Bcl-2 (DAKO, A/S), goat polyclonal N-12: VCP (Santa Cruz); 9E10 mAb: Myc-tagged VCP (Santa Cruz). As a control for equal amounts of protein loaded, we detected ␤-actin by mAb Clone AC-15 (Sigma).
Generation of SAP-expressing Retroviral Vector and Transduction of Target Cells.
A retroviral vector, pLXPOP was used to transduce the SAP gene in target cell lines. The pLXPOP was constructed from the pLNPOX vector (30) . SAP cDNA was amplified by PCR from a pcDNA3 plasmid carrying the SAP gene (kind gift from Dr. Janos Sumegi, Cincinnati Children's Hospital Medical Center, OH). The PCR product was cloned into the retroviral vector. The insert was later sequenced. Retrovirus particles were produced in the Phoenix cell line. The virus containing supernatant was collected, filtered through 0.45-m HT Tuffryn membrane filter (Pall Corporation), and polibrene (Sigma) was added to a final concentration of 4 g/mL. Thirty-six hours after infection of the target cells with this supernatant, selection of transduced cells was started with puromycin.
Expression Vectors and Transfections. The VCP cDNA was amplified from the pCMV-SPORT6 construct carrying the BC110913.1 clone sequence of VCP (RZPD German Resource Center for Genome Research). The sequence was then cloned into the pCMV-Myc vector (Clontech) and the insert was sequenced. Vectors were transfected into Saos-2 cells in 10-cm Petri dish by polyethyleneimine (PEI) technique. Forty-eight hours after transfection, the cells were collected, lysed, and subjected to coimmunoprecipitations.
Coimmunoprecipitations. Cells were lysed in cell lysis buffer (50 mM Tris, pH 7.6; 150 mM NaCl; 1% Nonidet P-40; 0.5% sodium deoxicholate; and 0.05% SDS) containing protease inhibitors mixture (Complete Mini, Roche) for 30 min on ice. Insoluble material was removed by centrifugation at 14,000 ϫ g for 15 min. Protein G-sepharose precleared lysates were incubated with rabbit anti-SAP or mouse anti-Myc antibodies overnight at 4°C. As control, equal volumes of lysates were incubated with normal rabbit serum or with normal mouse serum. Protein G-sepharose was added again for 2 h. The precipitates were washed 5 times with PBS containing protease inhibitor mixture. Affinity-bound protein complexes were released from protein-G beads by boiling in loading buffer and analyzed by SDS-PAGE.
Silver Staining and Mass Spectrometry. Immunoprecipitated samples were subjected to reduction and alkylation by pretreating them with DTT and iodoacetamide. After running them on SDS-PAGE, proteins were visualized by silver staining (31) . Relevant bands were excised and treated for in-gel digestion (32) . In brief, the silver stained bands were destained, dried and trypsin (Promega Corporation) was allowed to soak into the gel over ice. After incubation at 30°C overnight, the samples were acidified and the generated peptides were concentrated and desalted on a C18 ZipTip (Millipore). The peptide mixture was eluted with 70% ACN containing the matrix alfa-cyano-4-hydroxy-cinnamic acid directly onto the MALDI target. Spectra for peptide mass fingerprinting were obtained on a MALDI-TOF/TOF mass spectrometer (Ultraflex III, Bruker Daltonics) following the manufacturer's recommendation. Spectra were internally calibrated using autolytic peptides from trypsin resulting in an error Ͻ15 ppm. Search for identity was done via ProFound (http://prowl.rockefeller.edu). The searches were done totally un-biased, that is, no species, size or pI was specified.
